| Company/Division name | National Resilience Inc. |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2020 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 800 |
| City reshored to: | San Diego |
| State(s) reshored to: | CA |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals, Medical Equipment & Supplies, healthcare, biosciences |
| Product(s) reshored | gene therapies, viral vectors, vaccines, proteins |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Higher productivity, Impact on domestic economy, Lead time/Time to market, Proximity to customers/market, Skilled workforce availability/training, Other, Covid-19 |
